{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:23:10Z","timestamp":1775128990178,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T00:00:00Z","timestamp":1468368000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T00:00:00Z","timestamp":1468368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1R01AR059270-01"],"award-info":[{"award-number":["1R01AR059270-01"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009157","name":"National Institute on Disability, Independent Living, and Rehabilitation Research","doi-asserted-by":"publisher","award":["90SI5007-01-02"],"award-info":[{"award-number":["90SI5007-01-02"]}],"id":[{"id":"10.13039\/100009157","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["B6618R"],"award-info":[{"award-number":["B6618R"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["RX-000792-01A2"],"award-info":[{"award-number":["RX-000792-01A2"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00198-016-3678-4","type":"journal-article","created":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T14:37:11Z","timestamp":1468420631000},"page":"3503-3511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Wheelchair use and lipophilic statin medications may influence bone loss in chronic spinal cord injury: findings from the FRASCI-bone loss study"],"prefix":"10.1007","volume":"27","author":[{"given":"L. R.","family":"Morse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Battaglino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. R.","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zafonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Garshick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,13]]},"reference":[{"key":"3678_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1179\/1079026814Z.000000000260","volume":"37","author":"National Spinal Cord InjuryStatistical C","year":"2014","unstructured":"National Spinal Cord InjuryStatistical C (2014) Spinal Cord Injury Facts and Figures at a Glance. J Spinal Cord Med 37:355\u2013356","journal-title":"J Spinal Cord Med"},{"key":"3678_CR2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.bone.2012.04.019","volume":"51","author":"RA Battaglino","year":"2012","unstructured":"Battaglino RA, Sudhakar S, Lazzari AA, Garshick E, Zafonte R, Morse LR (2012) Circulating sclerostin is elevated in short-term and reduced in long-term SCI. Bone 51:600\u2013605","journal-title":"Bone"},{"key":"3678_CR3","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00198-013-2295-8","volume":"24","author":"LD Carbone","year":"2013","unstructured":"Carbone LD, Chin AS, Burns SP, Svircev JN, Hoenig H, Heggeness M, Weaver F (2013) Morbidity following lower extremity fractures in men with spinal cord injury. Osteoporos Int 24:2261\u20132267","journal-title":"Osteoporos Int"},{"key":"3678_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-008-0671-6","volume":"20","author":"LR Morse","year":"2009","unstructured":"Morse LR, Battaglino RA, Stolzmann KL, Hallett LD, Waddimba A, Gagnon D, Lazzari AA, Garshick E (2009) Osteoporotic fractures and hospitalization risk in chronic spinal cord injury. Osteoporos Int 20:385\u2013392","journal-title":"Osteoporos Int"},{"key":"3678_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.pmrj.2008.10.008","volume":"1","author":"LR Morse","year":"2009","unstructured":"Morse LR, Giangregorio L, Battaglino RA, Holland R, Craven BC, Stolzmann KL, Lazzari AA, Sabharwal S, Garshick E (2009) VA-based survey of osteoporosis management in spinal cord injury. PM R 1:240\u2013244","journal-title":"PM R"},{"key":"3678_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bone.2013.01.044","volume":"54","author":"J Liu","year":"2013","unstructured":"Liu J, Zhu LP, Yang XL, Huang HL, Ye DQ (2013) HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis. Bone 54:151\u2013156","journal-title":"Bone"},{"key":"3678_CR7","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.bone.2007.02.019","volume":"40","author":"B Uzzan","year":"2007","unstructured":"Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY (2007) Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone 40:1581\u20131587","journal-title":"Bone"},{"key":"3678_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/jbmr.2020","volume":"29","author":"AL Doherty","year":"2014","unstructured":"Doherty AL, Battaglino RA, Donovan J, Gagnon D, Lazzari AA, Garshick E, Zafonte R, Morse LR (2014) Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury. J Bone Miner Res 29:251\u2013259","journal-title":"J Bone Miner Res"},{"key":"3678_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00198-012-2072-0","volume":"24","author":"LR Morse","year":"2013","unstructured":"Morse LR, Sudhakar S, Lazzari AA, Tun C, Garshick E, Zafonte R, Battaglino RA (2013) Sclerostin: a candidate biomarker of SCI-induced osteoporosis. Osteoporos Int 24:961\u2013968","journal-title":"Osteoporos Int"},{"key":"3678_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.apmr.2008.12.004","volume":"90","author":"LR Morse","year":"2009","unstructured":"Morse LR, Lazzari AA, Battaglino R, Stolzmann KL, Matthess KR, Gagnon DR, Davis SA, Garshick E (2009) Dual energy x-ray absorptiometry of the distal femur may be more reliable than the proximal tibia in spinal cord injury. Arch Phys Med Rehabil 90:827\u2013831","journal-title":"Arch Phys Med Rehabil"},{"key":"3678_CR11","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1007\/s00198-014-2786-2","volume":"25","author":"CO Tan","year":"2014","unstructured":"Tan CO, Battaglino RA, Doherty AL, Gupta R, Lazzari AA, Garshick E, Zafonte R, Morse LR (2014) Adiponectin is associated with bone strength and fracture history in paralyzed men with spinal cord injury. Osteoporos Int 25:2599\u20132607","journal-title":"Osteoporos Int"},{"key":"3678_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/jbmr.546","volume":"27","author":"LR Morse","year":"2012","unstructured":"Morse LR, Sudhakar S, Danilack V, Tun C, Lazzari A, Gagnon DR, Garshick E, Battaglino RA (2012) Association between sclerostin and bone density in chronic spinal cord injury. J Bone Miner Res 27:352\u2013359","journal-title":"J Bone Miner Res"},{"key":"3678_CR13","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1007\/s00198-010-1478-9","volume":"22","author":"K Bleicher","year":"2011","unstructured":"Bleicher K, Cumming RG, Naganathan V, Seibel MJ, Sambrook PN, Blyth FM, Le Couteur DG, Handelsman DJ, Creasey HM, Waite LM (2011) Lifestyle factors, medications, and disease influence bone mineral density in older men: findings from the CHAMP study. Osteoporos Int 22:2421\u20132437","journal-title":"Osteoporos Int"},{"key":"3678_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S8756-3282(03)00034-6","volume":"32","author":"A Montagnani","year":"2003","unstructured":"Montagnani A, Gonnelli S, Cepollaro C, Pacini S, Campagna MS, Franci MB, Lucani B, Gennari C (2003) Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study. Bone 32:427\u2013433","journal-title":"Bone"},{"key":"3678_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1359\/jbmr.040209","volume":"19","author":"L Rejnmark","year":"2004","unstructured":"Rejnmark L, Buus NH, Vestergaard P, Heickendorff L, Andreasen F, Larsen ML, Mosekilde L (2004) Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res 19:737\u2013744","journal-title":"J Bone Miner Res"},{"key":"3678_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1136\/ip.8.4.276","volume":"8","author":"WA Ray","year":"2002","unstructured":"Ray WA, Daugherty JR, Griffin MR (2002) Lipid-lowering agents and the risk of hip fracture in a Medicaid population. Inj Prev 8:276\u2013279","journal-title":"Inj Prev"},{"key":"3678_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/EDE.0b013e31829eef0a","volume":"24","author":"LC McCandless","year":"2013","unstructured":"McCandless LC (2013) Statin use and fracture risk: can we quantify the healthy-user effect? Epidemiology 24:743\u2013752","journal-title":"Epidemiology"},{"key":"3678_CR18","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/S0140-6736(00)02408-9","volume":"355","author":"CJ Edwards","year":"2000","unstructured":"Edwards CJ, Hart DJ, Spector TD (2000) Oral statins and increased bone-mineral density in postmenopausal women. Lancet 355:2218\u20132219","journal-title":"Lancet"},{"key":"3678_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/archinte.162.5.537","volume":"162","author":"JA Pasco","year":"2002","unstructured":"Pasco JA, Kotowicz MA, Henry MJ, Sanders KM, Nicholson GC, Geelong Osteoporosis S (2002) Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study. Arch Intern Med 162:537\u2013540","journal-title":"Arch Intern Med"},{"key":"3678_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00198-004-1598-1","volume":"15","author":"HK Berthold","year":"2004","unstructured":"Berthold HK, Unverdorben S, Zittermann A, Degenhardt R, Baumeister B, Unverdorben M, Krone W, Vetter H, Gouni-Berthold I (2004) Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women. Osteoporos Int 15:459\u2013467","journal-title":"Osteoporos Int"},{"key":"3678_CR21","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.metabol.2004.01.010","volume":"53","author":"G Lupattelli","year":"2004","unstructured":"Lupattelli G, Scarponi AM, Vaudo G et al (2004) Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women. Metabolism 53:744\u2013748","journal-title":"Metabolism"},{"key":"3678_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00223-006-0024-4","volume":"79","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006) Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case\u2013control study. Calcif Tissue Int 79:27\u201336","journal-title":"Calcif Tissue Int"},{"key":"3678_CR23","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1359\/JBMR.040607","volume":"19","author":"MW Schoofs","year":"2004","unstructured":"Schoofs MW, Sturkenboom MC, van der Klift M, Hofman A, Pols HA, Stricker BH (2004) HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res 19:1525\u20131530","journal-title":"J Bone Miner Res"},{"key":"3678_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1042\/BSR20110118","volume":"32","author":"F Ruan","year":"2012","unstructured":"Ruan F, Zheng Q, Wang J (2012) Mechanisms of bone anabolism regulated by statins. Biosci Rep 32:511\u2013519","journal-title":"Biosci Rep"},{"key":"3678_CR25","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1074\/jbc.M606706200","volume":"282","author":"N Ghosh-Choudhury","year":"2007","unstructured":"Ghosh-Choudhury N, Mandal CC, Choudhury GG (2007) Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation. J Biol Chem 282:4983\u20134993","journal-title":"J Biol Chem"},{"key":"3678_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1006\/bbrc.2001.5597","volume":"287","author":"K Ohnaka","year":"2001","unstructured":"Ohnaka K, Shimoda S, Nawata H, Shimokawa H, Kaibuchi K, Iwamoto Y, Takayanagi R (2001) Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochem Biophys Res Commun 287:337\u2013342","journal-title":"Biochem Biophys Res Commun"},{"key":"3678_CR27","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","volume":"286","author":"G Mundy","year":"1999","unstructured":"Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946\u20131949","journal-title":"Science"},{"key":"3678_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1212\/WNL.0b013e3182a1aa68","volume":"81","author":"JJ Cragg","year":"2013","unstructured":"Cragg JJ, Noonan VK, Krassioukov A, Borisoff J (2013) Cardiovascular disease and spinal cord injury: results from a national population health survey. Neurology 81:723\u2013728","journal-title":"Neurology"},{"key":"3678_CR29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.2340\/16501977-0964","volume":"44","author":"P Flank","year":"2012","unstructured":"Flank P, Wahman K, Levi R, Fahlstrom M (2012) Prevalence of risk factors for cardiovascular disease stratified by body mass index categories in patients with wheelchair-dependent paraplegia after spinal cord injury. J Rehabil Med 44:440\u2013443","journal-title":"J Rehabil Med"},{"key":"3678_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sc.1992.87","volume":"30","author":"H Krum","year":"1992","unstructured":"Krum H, Howes LG, Brown DJ, Ungar G, Moore P, McNeil JJ, Louis WJ (1992) Risk factors for cardiovascular disease in chronic spinal cord injury patients. Paraplegia 30:381\u2013388","journal-title":"Paraplegia"},{"key":"3678_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/PHM.0b013e31802f0247","volume":"86","author":"J Myers","year":"2007","unstructured":"Myers J, Lee M, Kiratli J (2007) Cardiovascular disease in spinal cord injury: an overview of prevalence, risk, evaluation, and management. Am J Phys Med Rehabil 86:142\u2013152","journal-title":"Am J Phys Med Rehabil"},{"key":"3678_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2340\/16501977-0510","volume":"42","author":"K Wahman","year":"2010","unstructured":"Wahman K, Nash MS, Westgren N, Lewis JE, Seiger A, Levi R (2010) Cardiovascular disease risk factors in persons with paraplegia: the Stockholm spinal cord injury study. J Rehabil Med 42:272\u2013278","journal-title":"J Rehabil Med"},{"key":"3678_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2340\/16501977-0541","volume":"42","author":"K Wahman","year":"2010","unstructured":"Wahman K, Nash MS, Lewis JE, Seiger A, Levi R (2010) Increased cardiovascular disease risk in Swedish persons with paraplegia: The Stockholm spinal cord injury study. J Rehabil Med 42:489\u2013492","journal-title":"J Rehabil Med"},{"key":"3678_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2340\/16501977-0658","volume":"43","author":"K Wahman","year":"2011","unstructured":"Wahman K, Nash MS, Lewis JE, Seiger A, Levi R (2011) Cardiovascular disease risk and the need for prevention after paraplegia determined by conventional multifactorial risk models: the Stockholm spinal cord injury study. J Rehabil Med 43:237\u2013242","journal-title":"J Rehabil Med"},{"key":"3678_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbr.2016.04.046","volume":"309","author":"Z Sheng","year":"2016","unstructured":"Sheng Z, Jia X, Kang M (2016) Statin use and risk of Parkinson's disease: A meta-analysis. Behav Brain Res 309:29\u201334","journal-title":"Behav Brain Res"},{"key":"3678_CR36","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/anie.201204964","volume":"52","author":"T Silva","year":"2013","unstructured":"Silva T, Teixeira J, Remiao F, Borges F (2013) Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways. Angew Chem Int Ed Engl 52:1110\u20131121","journal-title":"Angew Chem Int Ed Engl"},{"key":"3678_CR37","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1227\/NEU.0b013e31828ab413","volume":"72","author":"GK Wong","year":"2013","unstructured":"Wong GK, Liang M, Tan H, Lee MW, Po YC, Chan KY, Poon WS (2013) High-dose simvastatin for aneurysmal subarachnoid hemorrhage: a multicenter, randomized, controlled, double-blind clinical trial protocol. Neurosurgery 72:840\u2013844","journal-title":"Neurosurgery"},{"key":"3678_CR38","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1586\/ern.12.88","volume":"12","author":"I Miedema","year":"2012","unstructured":"Miedema I, Uyttenboogaart M, Luijckx GJ (2012) Statin use and lipid profile in relation to safety and functional outcome after thrombolysis in ischemic stroke. Expert Rev Neurother 12:907\u2013910","journal-title":"Expert Rev Neurother"},{"key":"3678_CR39","first-page":"81","volume":"9","author":"E Esposito","year":"2012","unstructured":"Esposito E, Rinaldi B, Mazzon E, Donniacuo M, Impellizzeri D, Paterniti I, Capuano A, Bramanti P, Cuzzocrea S (2012) Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-alpha. J Neuroinflammation 9:81","journal-title":"J Neuroinflammation"},{"key":"3678_CR40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neulet.2012.05.071","volume":"521","author":"X Han","year":"2012","unstructured":"Han X, Yang N, Cui Y, Xu Y, Dang G, Song C (2012) Simvastatin mobilizes bone marrow stromal cells migrating to injured areas and promotes functional recovery after spinal cord injury in the rat. Neurosci Lett 521:136\u2013141","journal-title":"Neurosci Lett"},{"key":"3678_CR41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11481-012-9419-3","volume":"8","author":"A Shunmugavel","year":"2013","unstructured":"Shunmugavel A, Martin MM, Khan M, Copay AG, Subach BR, Schuler TC, Singh I (2013) Simvastatin ameliorates cauda equina compression injury in a rat model of lumbar spinal stenosis. J Neuroimmune Pharmacol 8:274\u2013286","journal-title":"J Neuroimmune Pharmacol"},{"key":"3678_CR42","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/sj.sc.3100648","volume":"36","author":"P Vestergaard","year":"1998","unstructured":"Vestergaard P, Krogh K, Rejnmark L, Mosekilde L (1998) Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord 36:790\u2013796","journal-title":"Spinal Cord"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3678-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-016-3678-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3678-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T07:36:03Z","timestamp":1589441763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-016-3678-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,13]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["3678"],"URL":"https:\/\/doi.org\/10.1007\/s00198-016-3678-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,13]]},"assertion":[{"value":"8 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Leslie Morse, Nguyen Nguyen, Ricardo Battaglino, A J Guarino, David Gagnon, Ross Zafonte, and Eric Garshick declare that they have no conflict of interest. This study received support from: The National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR059270-01], National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR 90SI5007-01-02), The Office of Research and Development, Rehabilitation Research and Development [Merit Review Grant B6618R and RX-000792-01A2], and The Massachusetts Veterans Epidemiology Research and Information Center, Cooperative Studies Program, Department of Veterans Affairs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}